Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: A University of Pennsylvania phase II trial

Journal of Clinical Oncology

Volumn 20, Issue 19, 2002, Pages 3964-3971

  Machtay, Mitchell ^a   Rosenthal, David I ^a   Hershock, Diane ^a   Jones, Heather ^a   Williamson, Shirnett ^a   Greenberg, Michael J ^a   Weinstein, Gregory S ^a   Aviles, Victor M ^a   Chalian, Ara A ^a   Weber, Randal S ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; ARTICLE; ASPIRATION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DYSPHAGIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NECK DISSECTION; ORGAN PRESERVATION; OROPHARYNX; OROPHARYNX CARCINOMA; PHASE 2 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TIME; ULCER; UNITED STATES;

EID: 0036787771     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.11.026     Document Type: Article

References (56)

1. Fein DA, Lee WR, Amos WR, et al: Oropharyngeal carcinoma treated with radiotherapy: A 30-year experience. Int J Radiat Oncol Biol Phys 34:289-296, 1996
2. Sessions DG: Surgical resection and reconstruction for cancer of the base of tongue. Otalaryngol Clin North Am 16:309-322, 1983
3. Perez CA, Carmichael T, Devineni WR, et al: Carcinoma of the tonsillar fossa: A nonrandomized comparison of preoperative radiation and surgery or irradiation alone-Long term results. Head Neck 13:282-290, 1991
4. Machtay M, Perch S, Markiewicz D, et al: Combined surgery and postoperataive radiotherapy for carcinoma of the base of tongue. Head Neck 19:494-499, 1997
5. Marcial VA, Hanley JA, Hendrickson F, et al: Split course radiation therapy of carcinoma of the base of the tongue: Results of a prospective national collaborative clinical trial conducted by the RTOG. Int J Radiat Oncol Biol Phys 9:437-443, 1983
6. Zelefsky MJ, Harrison LB, Armstrong JG: Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma. Cancer 70:2388-2395, 1992
7. Kramer S, Gelber RD, Snow JB, et al: Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 10:19-30, 1987
8. Kraus DH, Vastola AP, Huvos AG, et al: Surgical management of squamous cell carcinoma of the base of the tongue. Am J Surg 166:384-388, 1993
9. DeNittis AS, Machtay M, Rosenthal DI. et al: Advanced resectable oropharyngeal carcinoma treated with surgery and postoperative radiotherapy: Oncologic outcome and functional assessment. Am J Otolaryngol 22:329-335, 2001
10. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer: The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324:1685-1690, 1991
11. Machtay M, Rosenthal DI, Algazy KM, et al: Pilot study of organ preservation multimodality therapy for locally advanced resectable oropharyngeal carcinoma. Am J Clin Oncol 23:509-515, 2000
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
13. Radiation Therapy Oncology Group: RTOG Toxicity Criteria. Philadelphia, American College of Radiology-Radiation Therapy Oncology Group, 2000
14. List MA, Ritter-Sterr C, Lansky SB: A performance status scale for head and neck cancer patients. Cancer 66:564-569, 1990
15. Kies MS, Haraf DJ, Athanasiadis I, et al: Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: Improved disease control and survival. J Clin Oncol 16:2715-2721, 1998
16. Mantz CA, Vokes EE, Stenson K, et al: Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer. Cancer J 7:140-148, 2001
17. Giralt JL, Gonzalez J, del-Campo JM, et al: Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx. Cancer 89:939-945, 2000
18. Vokes EE, Kies M, Haraf DJ, et al: Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease. J Clin Oncol 13:876-883, 1995
19. Vokes EE, Weichselbaum RR, Mick R, et al: Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 84:877-882, 1992
20. Adelstein DJ, Saxton JP, Lavertu P, et al: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results. Head Neck 19:567-575, 1997
21. Taylor SG IV, Murthy AK, Vannetzel JM, et al: Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 12:385-395, 1994
22. Wendt TG, Grabenbauer CG, Rodel CM, et al: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 16:1318-1324, 1998
23. Robbins KT, Kumar P, Regine WF, et al: Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: The Memphis experience. Int J Radiat Oncol Biol Phys 38:263-271, 1997
24. Harrison LB, Raben A, Pfister DG, et al: A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck. Head Neck 20:497-503, 1998
25. Adelstein DJ, Saxton JP, Lavertu P, et al: Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol 20:1405-1410, 2002
26. Lefebvre JL, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 88:890-899, 1996
27. Pfister DG, Harrison LB, Strong EW, et al: Organ-function preservation in advanced oropharynx cancer: Results with induction chemotherapy and radiation. J Clin Oncol 13: 671-680, 1995
28. Demard F, Chauvel P, Santini J, et al: Response to chemotherapy as justification for modification of therapeutic strategy for pharyngolaryngeal carcinomas. Head Neck 12:225-231, 1990
29. Calais G, Alfonsi M, Bardet E, et al: Randomized study comparing radiation alone RT versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081-2086, 1999
30. Domenge C, Hill C, Lefebvre JL: Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. Br J Cancer 83: 1594-1598, 2000
31. Pignon JP, Bourhis J, Domenge C, et al: Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: Three meta-analyses of updated individual data. Lancet 355:949-955, 2000
32. Pinnaro P, Cercato MC, Giannarelli D, et al: A randomized phase II study comparing sequential versus simultaneous chemoradiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck. Ann Oncol 5:513-519, 1994
33. Forastiere AA, Berkey B, Maor M, et al: Phase III trial to preserve the larynx: Induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, intergroup trial R91-11. Proc Am Soc Clin Oncol 20:2a, 2001 (abstr 4)
34. Alvi A, Johnson JT: Development of distant metastases after treatment of advanced stage head and neck cancer. Head Neck 19:500-505, 1997
35. Shingaki S, Suzuki I, Kobayashi T, et al: Predicting factors for distant metastases in head and neck carcinomas: An analysis of 103 patients with locoregional control. J Oral Maxillofac Surg 54:853-857, 1996
36. Calhoun KH, Fulmer P, Weiss R, et al: Distant metastases from head and neck squamous cell carcinomas. Laryngoscope 104:1199-1205, 1994
37. Vikram B, Strong EW, Shah JP, et al: Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg 6:730-733, 1984
38. Koness RJ, Glicksman A, Liu L, et al: Recurrence patterns with concurrent platinum-based chemotherapy and accelerated hyperfractionated radiotherapy in stage III and IV head and neck cancer patients. Am J Surg 174:532-535, 1997
39. Kies MS, Haraf DJ, Rosen F, et al: Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 19:1961-1969, 2001
40. Lavertu P, Adelstein DJ, Saxton JP, et al: Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: An 8-year single institution experience. Arch Otolaryngol Head Neck Surg 125:142-148, 1999
41. Head/Neck Contracts Program: Adjuvant chemotherapy for advanced head and neck squamous cell carcinoma: Final report of the Head and Neck Contracts Program. Cancer 60:301-311, 1987
42. Laramore GE, Scott CB, Al-Saraff M, et al: Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck: Report on Intergroup study 0034. Int J Radiat Oncol Biol Phys 23:705-713, 1992
43. Al-Sarraf M, LeBlanc M, Giri PG, et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 16:1310-1317, 1998
44. Rosenthal DI, Pistenmaa DA, Glatstein E: A review of neoadjuvant chemotherapy for head and neck cancer: Partially shrunken tumors may be both leaner and meaner. Int J Radiat Oncol Biol Phys 28:315-320, 1994
45. Fu KK, Pajak TF, Trotti A, et al: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 90-03. Int J Radiat Oncol Biol Phys 48:7-16, 2000
46. Bourhis J, Lapeyre M, Tortochaux J, et al: Very accelerated versus conventional radiotherapy in HNSCC: Results of the GORTEC 94-02 randomized trial. Proc Am Soc Ther Radiol 48:111, 2000 (abstr 2)
47. Machtay M, Aviles V, Kligerman MM, et al: A phase I trial of 96-hour taxol infusion plus accelerated radiotherapy for unresectable head and neck cancer. Int J Radiat Oncol Biol Phys 44:311-315, 1999
48. Wolden SL, Zelefsky MJ, Kraus DH, et al: Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol 19:1105-1110, 2001
49. Budach VG, Dinges S, Haake K, et al: Accelerated chemoradiation to 70.6 Gy is more effective than accelerated radiation to 77.6 Gy alone: Two year results of a German multicentre randomized trial. Proc Am Soc Ther Radiol 48:150-151, 2000 (abstr 78)
50. Staar S, Rudat V, Stuetzer H, et al: Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy: Results of a multicentric randomized German trial in advanced head and neck cancer. Proc Am Soc Ther Radiol 48:151-152, 2000 (abstr 80)
51. List MA, Siston A, Haraf D, et al: Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: A prospective examination. J Clin Oncol 17:1020-1028, 1999
52. Butler BE, Teh BS, Grant WH, et al: Simultaneous modulated accelerated radiation therapy boost for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 45:21-32, 1999
53. Brizel DM, Wasserman TH, Henke M, et al: Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18:3339-3345, 2000
54. Bonner JA, Ezekiel MP, Robert F, et al: Continued response following treatment with IMC-C225, an EGFRMoAb, combined with RT in advanced head and neck malignancies. Proc Am Soc Clin Oncol 19:4a, 2000 (abstr 5F)
55. Buntzel J, Kuttner K, Frohlich D, et al: Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer. Ann Oncol 9:505-509, 1998
56. Antonadou D, Synodinous M, Boufi M, et al: Amifostine reduces acute toxicity during radiochemotherapy in patients with localized advanced stage NSCLC. Proc Am Soc Clin Oncol 19:501, 2000 (abstr 1960)